Skip to main content

CFC eyeing up £5bn+ London Stock Exchange listing – FT

Stock market

CFC is exploring options including listing on the London Stock Exchange, according to the Financial Times.

The article put the potential value of the private-equity backed specialist insurer at more than £5bn.

It noted that discussions were at an early stage and that other options were being considered, such as listing in the US or a sale, with no deal expected before the second half of 2026.

PE house EQT invested in CFC in 2021, joining Vitruvian Partners, which had been a financial backer since 2017.

The 2021 deal valued CFC for a reported £2.5bn when it had over 500 staff.

Pioneer

Headquartered in

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@insuranceage.co.uk or view our subscription options here: https://subscriptions.insuranceage.co.uk/subscribe

You are currently unable to copy this content. Please contact info@insuranceage.co.uk to find out more.

Register

Sign up and gain access to five complimentary news articles every month.

Already have an account? Sign in here

Broker Expo 2025 Countdown: Beazley’s Sam Franks

As we count down to Broker Expo in October, we caught up with Sam Franks, country manager and head of partner engagement – UK and Ireland – at exhibitor Beazley, who explains how it can work with brokers to help clients build their resilience in an uncertain environment.

PremFina leaders tackle growth, profitability and regulation changes

As PremFina restructures for “the next stage of the journey”, chief product and revenue officer Laura Sweetman and chief strategy officer Danielle Medhurst share how it will partner with brokers en route to reaching profitability by the end of June next year and £1.9bn in premium finance volume by 2027.

You need to sign in to use this feature. If you don’t have an Insurance Age account, please register now.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an indvidual account here: